New Market - February 10, 2025
Boule Diagnostics enters distribution agreement
Boule Diagnostics has entered into an exclusive distribution agreement with VitalScientific for the US market.
MedTech Business - February 3, 2025
Suturion receives FDA clearance
The US Food and Drug Administration (FDA) has granted clearance for the surgical device SutureTOOL.
Biotech Business - January 27, 2025
Oncopeptides’ Pepaxti formally approved for full reimbursement in Italy
The positive reimbursement decision for Pepaxti (melflufen) has been published in the Italian Official Journal.
New Market - January 20, 2025
AstraZeneca’s Datroway approved in the US
First approval in the US for AstraZeneca and Daiichi Sankyo’s Datroway based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or death vs. chemotherapy.
New Market - January 15, 2025
ALK’s ACARIZAX approved in Europe for treatment of young children
ALK has announced that its European regulatory filing for ACARIZAX (house dust mite sublingual allergy immunotherapy tablet) in young children aged five to 11 has been approved by the health authorities in 21 EU countries via a type II variation procedure.
New Market - December 3, 2024
American IonQ opens operation in Gothenburg
IonQ has set up in Gothenburg, primarily through a new development center at AstraZeneca BioVentureHub.
